Capricor Therapeutics Inc

NASDAQ:CAPR  
4.99
+0.26 (+5.50%)
Earnings Announcements

Capricor Therapeutics Reports Second Quarter 2021 Financial Results And Provides Corporate Update

Published: 08/12/2021 20:46 GMT
Capricor Therapeutics Inc (CAPR) - Capricor Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update.
Capricor Therapeutics Inc - Net Loss of Approximately $4.7 Million, Or $0.21 per Share, for the Three Months Ended June 30, 2021.
Revenue is expected to be $0.21 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0.39 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.